Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis

Evangelos Pavlakis, Thorsten Stiewe|Journal of Experimental & Clinical Cancer Research|2023

Cited by 19